| 1 (201) | Novo Nordisk A/S | DNK |  |
| 2 (238) | AstraZeneca, United Kingdom | GBR | |
| 3 (260) | Novartis Institutes for Biomedical Research, Switzerland | CHE | |
| 4 (264) | Philips Research, Eindhoven | NLD | |
| 5 (265) | Hoffmann-La Roche, GmbH., Germany | DEU | |
| 6 (305) | AstraZeneca, Sweden | SWE | |
| 7 (326) | Merck KGaA, Germany | DEU | |
| 8 (346) | Bayer AG, Germany | DEU | |
| 9 (494) | Hoffmann-La Roche Ltd, Switzerland | CHE | |
| 10 (500) | Boehringer Ingelheim GmbH Germany | DEU | |
| 11 (526) | Janssen Research & Development, LLC | BEL | |
| 12 (567) | IMEC International | BEL | |
| 13 (625) | Sanofi, France | FRA | |
| 14 (640) | GlaxoSmithKline, United Kingdom | GBR | |
| 15 (778) | Pfizer Inc, Spain | ESP | |
| 16 (804) | Nestle Switzerland | CHE | |
| 17 (822) | VTT Technical Research Centre of Finland | FIN | |
| 18 (829) | Novartis, Switzerland | CHE | |
| 19 (872) | BASF, Germany | DEU | |
| 20 (1316) | UCB Pharma SA, Belgium | BEL | |
| 21 (1334) | Bosch, Germany | DEU | |
| 22 (1419) | Siemens AG, Germany | DEU | |
| 23 (1740) | GlaxoSmithKline, Belgium | BEL | |
| 24 (2031) | Syngenta, United Kingdom | GBR | |
| 25 (2045) | SINTEF Group * | NOR | |
| 26 (2102) | Siemens Healthineers, Germany | DEU | |
| 27 (3015) | European XFEL GmbH | DEU | |
| 28 (3495) | Sincrotrone Trieste | ITA | |
|
